Sol-Gel Technologies Ltd. Stock

$7.57

1.30% today

Nasdaq, May 16, 04:19 pm CET

ISIN

IL0011417206

Symbol

SLGL

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Pharmaceuticals

Overview Dividends Analysts Charts News Strategies

Sol-Gel Technologies Ltd. Stock price

$7.67

-66.83 89.71% 5Y

Nasdaq, Closing price Thu, May 15 2025

-0.14 1.84%

ISIN

IL0011417206

Symbol

SLGL

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Pharmaceuticals

Key metrics

Market capitalization	$21.37m
Enterprise Value	$-1.25m
P/E (TTM) P/E ratio	negative
EV/Sales (TTM) EV/Sales	-0.11
P/S ratio (TTM) P/S ratio	1.85
P/B ratio (TTM) P/B ratio	7.41
Revenue growth (TTM) Revenue growth	473.46%
Revenue (TTM) Revenue	$11.54m
EBIT (operating result TTM) EBIT	$-12.02m
Cash position	$23.93m
EPS (TTM) EPS	$-0.38
P/E forward	negative
P/S forward	1.99
EV/Sales forward	negative
Short interest	1.09%

As a Free StocksGuide user, you can view scores for all 6,785 stocks worldwide.

Get Started for Free Today

Sol-Gel Technologies Ltd. Stock Analysis

Unlock Scores for Free

??

1 Analyst has issued a forecast Sol-Gel Technologies Ltd.:

1x Buy

100%

More details on Analyst Estimates Including Price Targets

1 Analyst has issued a forecast Sol-Gel Technologies Ltd.:

Buy

100%

Analyst Estimates with Stock Price Targets

Financial data from Sol-Gel Technologies Ltd.

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Dec '24		+/- %
Revenue	12 12	474% 474% 100%
- Direct Costs	- -	- -
Gross Profit	- -	- -
- Selling and Administrative Expenses	5.75 5.75	22% 22% 50%
- Research and Development Expense	18 18	24% 24% 154%
EBITDA	- -	- -
- Depreciation and Amortization	- -	- -
EBIT (Operating Income) EBIT	-12 -12	58% 58% -104%
Net Profit	-11 -11	60% 60% -92%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Sol-Gel Technologies Ltd. Stock News

Neutral

GlobeNewsWire

●

15 days ago

Sol-Gel Announces Reverse Share Split

NESS ZIONA, Israel, May 01, 2025 (GLOBE NEWSWIRE) -- Sol-Gel Technologies Ltd. (the “Company”) (NASDAQ: SLGL), a clinical-stage dermatology company, today announced a reverse share split (the “Reverse Split”) of the Company's issued and outstanding ordinary shares, par value NIS 0.1 per share (the “Ordinary Shares”), at the ratio of 10-for-1, such that each ten (10) Ordinary Shares shall be con...

Neutral

GlobeNewsWire

●

29 days ago

Sol-Gel and Mayne Pharma Announce the Purchase of EPSOLAY® and TWYNEO® in the U.S.

Sol-Gel to receive $16 million during 2025 Cash runway is expected to extend into the first quarter of 2027; Company expects to have sufficient cash to complete its Phase III clinical trial SGT-610 Phase III clinical trial top-line results are expected in the fourth quarter of 2026; a significant milestone in the clinical trial of recruiting more than 80% of the patients has been achieved Sol-G...

Neutral

GlobeNewsWire

●

about one month ago

Global Sol-Gel Coatings Market Research 2025-2035: Competitive Landscape, Functional Properties and Applications, End-users, Technology Fundamentals, Overview and Growth Analysis

This detailed market intelligence publication offers valuable insights into the innovative technologies, competitive landscape, and emerging opportunities that are reshaping the global surface engineering industry through 2035. This detailed market intelligence publication offers valuable insights into the innovative technologies, competitive landscape, and emerging opportunities that are resha...

More Sol-Gel Technologies Ltd. News

Company Profile

Sol-Gel Technologies Ltd. is a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. Its products include VERED, TWIN, and SIRS-T. The company was founded by David Avnir and Alon Seri-Levy on October 28, 1997 and is headquartered in Ness Ziona, Israel.

Head office	Israel
CEO	Moshe Arkin
Employees	34
Founded	1997
Website	www.sol-gel.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now